CFLAR and nonpapillary renal cell carcinoma: However, knockdown of c-FLIP led to an increase in RelA/p65 phosphorylation, indicating that c-FLIP inhibits NF-κB in ccRCC, which is consistent with reports showing an inhibitory role of c-FLIP on NF-kB in the context of death receptor signaling25–27.